FKBP5 rs9470079: Understanding Stress Response and Cortisol
The rs9470079 variant is a genetic change located within the FKBP5 gene, which plays a critical role in regulating the body's stress response system. Research suggests this variant is associated with altered cortisol suppression, potentially influencing how an individual's HPA axis manages stress.
What each genotype means
Altered cortisol feedback
This genotype is associated with decreased cortisol suppression, which may indicate altered negative feedback mechanisms in the HPA axis. Research suggests this variant may influence stress vulnerability, though these effects are complex and not diagnostic of any specific condition.
The frequency of this genotype varies by ancestry and is considered a less common variant compared to the major allele.
Potential stress response variation
Carriers of this genotype may show intermediate characteristics regarding HPA axis feedback regulation. Some studies have observed associations between this genotype and reduced risk for certain conditions like coronary artery disease in specific populations, though findings are not universal across all groups.
This is a common heterozygous genotype found in many populations worldwide.
Typical stress response profile
This is the major homozygous genotype for this variant. It is often used as the reference point in research studies investigating the role of FKBP5 in HPA axis regulation and stress-related psychopathology.
This is the most common genotype for this variant across most studied human populations.
What is the rs9470079 Variant?
The rs9470079 variant is a single nucleotide polymorphism (SNP) located within the FKBP5 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant involves a change between the G and A alleles. The FKBP5 gene provides instructions for making a protein called FKBP51, which acts as a co-chaperone for the glucocorticoid receptor. By sitting within this gene, the rs9470079 variant may influence the expression or function of the FKBP51 protein, thereby affecting the sensitivity of the glucocorticoid receptor. Because this receptor is essential for the negative feedback loop that turns off the body's stress response, variations in this region are of significant interest to researchers studying how different people physiologically react to and recover from stressful events.
The Role of the FKBP5 Gene
The FKBP5 gene is a key player in the hypothalamic-pituitary-adrenal (HPA) axis, the body's primary neuroendocrine system for managing stress. When the body perceives stress, the HPA axis triggers the release of cortisol, often called the 'stress hormone.' To prevent cortisol levels from remaining elevated for too long, the body uses a negative feedback mechanism where cortisol binds to glucocorticoid receptors to signal the HPA axis to slow down production. The FKBP51 protein, encoded by the FKBP5 gene, helps regulate this process by modulating the sensitivity of these receptors. When FKBP5 function is altered, it can disrupt this feedback loop, potentially leading to prolonged or inefficient cortisol regulation. This biological pathway is highly relevant to understanding how genetic differences contribute to variations in stress resilience and susceptibility to stress-related conditions.
Research Associations and Evidence
Scientific research has investigated the link between rs9470079 and various health outcomes, particularly those involving the HPA axis. Studies have observed that the A allele of rs9470079 is associated with decreased cortisol suppression, suggesting a potential impact on the efficiency of the HPA axis negative feedback mechanism. Some research has explored whether this variant is linked to susceptibility to conditions like major depressive disorder, bipolar disorder, or even comorbid coronary artery disease and depression, particularly in specific populations. However, the evidence strength for these associations is considered moderate. Findings are often context-dependent, sometimes showing effects only in specific genders or ethnic groups, such as in studies of Northern Chinese populations. Because these associations are complex and influenced by environmental factors like childhood trauma or life stress, the scientific community views these results as indicators of potential vulnerability rather than definitive predictors of disease.
Population Frequency
The rs9470079 variant is considered a common genetic variation. Its frequency varies across different ancestral populations, which is typical for many SNPs in the human genome. Because it is common, a significant portion of the general population carries at least one copy of the variant allele, making it a frequent subject of study in large-scale genetic research.
What This Information Means for You
Understanding your genotype for rs9470079 provides insight into your genetic makeup regarding stress-related biological pathways, but it does not serve as a medical diagnosis. Genetic associations with complex traits like stress response are influenced by a wide array of factors, including other genes, lifestyle, and environmental history. You cannot use this information to predict specific health outcomes or to guide medical treatment on your own. If you are concerned about stress, mental health, or how your body responds to medication, it is essential to consult with a qualified healthcare professional or a psychiatrist. They can provide a comprehensive evaluation that considers your full medical history, symptoms, and clinical needs. Never make changes to your medication or health regimen based on genetic data without direct guidance from your clinician or pharmacist.
How common is this variant?
The rs9470079 variant is common across global populations, though specific allele frequencies differ by ancestry.
Frequently asked questions
Does having the rs9470079 variant mean I will develop depression?
No. While some research suggests an association between this variant and stress-related conditions, it is not a diagnostic marker. Many people with this variant do not develop these conditions, as they are influenced by a complex mix of genetics, environment, and life experiences.
Can I use this SNP to choose the right antidepressant?
No. While FKBP5 variants are studied in the context of treatment response, there is no clinical consensus to use rs9470079 to guide medication selection. Always discuss your treatment options and any concerns about medication efficacy with your doctor or pharmacist.
What is the HPA axis?
The HPA axis is the hypothalamic-pituitary-adrenal axis, a complex set of direct influences and feedback interactions among three endocrine glands. It is the body's primary system for managing the physiological response to stress.
Is this variant the same as other FKBP5 SNPs?
No. FKBP5 is a large gene with many different SNPs, such as rs1360780 or rs4713902. Each SNP has its own unique research history and potential associations, and they should not be confused with one another.
Sources & further reading
Educational information only, last refreshed 10/30/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs9470079?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in FKBP5
This variant is associated with lithium treatment effectiveness and the modulation of responses to stressful situations in individuals with bipolar disorder.
This intronic variant in the FKBP5 gene modulates glucocorticoid receptor sensitivity and is linked to altered stress reactivity and susceptibility to psychiatric conditions like PTSD and depression.
Intronic variant in FKBP5; while FKBP5 is a well-established stress-response gene, specific associations for rs4713919 with HPA axis dynamics are less robustly replicated than other variants like rs1360780.
Modulates FKBP5 chaperone expression and alters glucocorticoid receptor sensitivity and negative feedback regulation of the HPA axis.
Regulatory variant in FKBP5 affecting glucocorticoid receptor chaperone activity and susceptibility to stress-related neuropsychiatric outcomes.
Intronic regulatory variant within FKBP5 linked to altered glucocorticoid receptor sensitivity and acute cortisol response following psychosocial stress.